Articles tagged with "GW Pharma"
8 total articles - Page 1 of 1
![epidiolex, descheduled, gw pharmaceuticals]()
DEA loosens rules on prescription CBD drug Epidiolex
David Downs - Published on April 6, 2020Read morePrescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year.
![]()
Is CBD Oil Legal Now? With Epidiolex Approved, It’s Still Not Clear
Ben Adlin - Published on June 25, 2018Read moreThe FDA just approved the CBD drug Epidiolex. Here’s what that means for the legal status of CBD oil nationwide.
![]()
Study Finds CBD Drug Epidiolex Reduces Seizures by 42%
Ryan Basen - Published on May 16, 2018Read moreHigh daily doses of CBD significantly reduced seizures in patients with Lennox-Gastaut syndrome.
![]()
Cannabis Investing: Does Revenue Even Matter?
Alan Brochstein, The Cannabis Capitalist - Published on November 6, 2017Read moreRevenue generation isn’t always rewarded by the stock market. Here’s how to read revenue figures, and why you should dive deeper before investing.
![]()
South Dakota House Blunts GW Pharma Bill
Bruce Barcott - Published on March 2, 2017Read moreThe bill would have given GW a temporary monopoly on CBD in the state. New language moves all forms of CBD to Schedule IV.
![]()
GW Pharma Responds: ‘Not Creating a Monopoly’
Bruce Barcott - Published on February 22, 2017Read moreThe pharmaceutical developer says it’s pioneering markets, not elbowing out competitors.
![]()
Leafly Exclusive: GW Pharma Is Moving CBD Bills on the Down Low
Bruce Barcott - Published on February 17, 2017Read moreThe proposed state measures would give the British pharma company’s new drug–but not other CBD products–legal status.
![]()
The Shake: Denver Has Growhouse Brokers, and Miami Cops Bust Man with Majestic Half-Beard
Lisa Rough - Published on April 25, 2016Read moreLegalization advocates are at the White House today, a Utah study shows further potential for cannabis epilepsy treatment, and seriously, this guy’s beard.
